AMENDMENT AGREEMENT – AMENDMENT NO.4 TO THE PRODUCT AGREEMENT DATED JULY 28, 2017Product Agreement • March 14th, 2022 • Paratek Pharmaceuticals, Inc. • Pharmaceutical preparations
FIFTH AMENDMENT TO THE AMENDED AND RESTATED MANUFACTURING AND SERVICES AGREEMENTManufacturing and Services Agreement • March 14th, 2022 • Paratek Pharmaceuticals, Inc. • Pharmaceutical preparations
This Fifth Amendment to the Amended and Restated Manufacturing and Services Agreement (the “Fifth Amendment”) is made as of January 11, 2022 (the “Effective Date”) by and between Paratek Pharmaceuticals, Inc., a Delaware corporation with a principal business address at 1000 First Avenue, Suite 200, King of Prussia, PA 19406 (“Paratek”) and CIPAN ̵̶ Companhia Industrial Produtora de Antibióticos, S.A., a corporation organized and existing under the laws of Portugal with an address at Rua da Estação, no42, 2600-726 Castanheira do Ribatejo, Portugal (“CIPAN” and together with Paratek, the “Parties”). Capitalized terms used, but not otherwise defined, herein shall have the meanings set forth in the Agreement.
